cAMP-Dependent Protein Kinase Inhibitor-α (5-22) amide is a potent regulatory fragment used to probe structural determinants of kinase inhibition. Its ordered sequence targets the catalytic cleft of PKA, enabling detailed mechanistic study. Researchers employ it in assays investigating phosphorylation networks. The peptide supports modeling of kinase-substrate interactions across species.
CAT No: P6403
CAS No:100853-58-5
Synonyms/Alias:PKI-α (5-22) amide (human, mouse, rabbit, rat), Wiptide
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
5. The spatiotemporal control of signalling and trafficking of the GLP-1R
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.